Dastanib - new drug for mesothelioma under trial

2009-10-06 02:30:54 (GMT) (Caymanmama.com - Mesothelioma News News)

Dallas, TX: Many drugs and treatments methods have been tested and tried on selected group of mesothelioma patients time and again. No cure has yet been discovered. New hope has arisen in mesothelioma patients with the discovery of a new drug named Dastanib. This drug is under study and clinical trials of the same are underway at M.D.Cancer Center - University of Texas and in different centers in the US.

The selected patients in the Anderson cancer center are receiving an additional and exceptional care through a dedicated team of doctors, who have been assigned specific roles for the treatment of different jobs, for the better treatment of these patients. This team is based on experts in thoracic medical oncology, radiation and pulmonary and pathological fields.

Dastanib, is useful for those mesothelioma patients, who are not responding to other available therapies or those who are unable to consume some drugs due to allergic reactions, or those, in whom, some side effects cause some trouble.

Mesothelioma is scary and till now, like other forms of cancer, is incurable. Though many asbestos industry workers are infected with this disease and many efforts have been made by the researchers to find a cure to this rear yet lethal disease but the researchers have failed to come up with any permanent cure for mesothelioma cancer and the victims, who have little time left to live, are forced to take up therapies like radiation therapies, chemotherapy etc.

The M. D. Cancer Center at University of Texas is trying its level best, through the introduction of this drug, to reduce and prevent the progression of this disease.

Dastanib - new drug for mesothelioma under trial

Comments

Articles

Other News / Press Releases

Archives

Mesothelioma News

Dastanib - new drug for mesothelioma under trial

Comments

Articles

Other News / Press Releases

News Tags

Archives